QA: Skye Bioscience Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516551_2022_Skye_Bioscience_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001516551')"}

Graph

Absolute values for 0001516551, Skye Bioscience Inc.

  xvar xval
0 AssetsCurrent 9,612,097
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 87,710
3 remainder_Assets 155,281
4 LiabilitiesCurrent 3,912,222
5 LiabilitiesNoncurrent 78,700
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,916,277
9 ResearchAndDevelopmentExpense 2,931,437
10 remainder_Expenses 2,100
11 remainder_Revenues 0
12 remainder_NetIncome -672,368
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 9,855,088
1 Liabilities 3,990,922
2 Expenses 7,849,814
3 Revenues 0
4 StockholdersEquity 5,864,166
5 NetIncome -8,522,182
6 ComprehensiveNetIncome -8,522,182
7 BaseVar 11,184,096
8 EconomicCapitalRatio 0.226

Edgar->Model Mapping

Feature Distribution

Change over Time